nach oben

European Journal of Nutrition

Erschienen in:

01.04.2019 | Original Contribution

Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study

verfasst von: Zhan-yong Chen, Meng Liu, Li-peng Jing, Mian-li Xiao, Hong-li Dong, Geng-dong Chen, Yu-ming Chen

Erschienen in: European Journal of Nutrition | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Previous studies have shown that high-dose supplementation with n-3 polyunsaturated fatty acids (PUFAs) may benefit patients with nonalcoholic fatty liver disease (NAFLD), but the association of n-3 PUFAs with NAFLD among individuals with normal diets is only speculative. We investigated the cross-sectional and prospective associations between n-3 PUFAs and NAFLD in Chinese adults.

Methods

This community-based prospective study included 3049 men and women (40–75 years) in Guangzhou, China, whose participants completed an NAFLD ultrasound evaluation and erythrocyte PUFA tests. A total of 2660 participants underwent the second NAFLD evaluation approximately 3 years later. α-Linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in erythrocytes were measured by gas chromatography.

Results

After adjusting for potential confounders, we observed inverse associations between DHA, DHA + EPA, total n-3 PUFAs and the presence of NAFLD in the cross-sectional analysis. The adjusted odds ratios (95% confidence interval) of NAFLD for the highest (vs. lowest) tertile were 0.74 (0.61, 0.90) for DHA, 0.82 (0.67, 1.00) for EPA, 0.73 (0.60, 0.88) for DHA + EPA and 0.74 (0.61, 0.91) for total n-3 PUFAs (all P values≤0.05). Over the average 3.12 years of follow-up, higher levels of DHA was associated with an improvement of NAFLD. The hazard ratio of improved NAFLD for the highest tertile was 1.18 (95% CI 1.09, 1.33) for DHA. Pathway analyses showed that favorable associations may be mediated by improvements in inflammatory markers (e.g., interleukin 1 beta and tumor necrosis factor alpha-like).

Conclusions

Erythrocyte membrane n-3 PUFAs are inversely associated with the presence and progression of NAFLD in Chinese adults.

Trial registrations

ClinicalTrials.gov NCT03179657.

Nur mit Berechtigung zugänglich

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73–84. https://doi.org/10.1002/hep.28431 CrossRef

Sun Q, Ma J, Campos H, Hankinson SE, Hu FB (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86(1):74–81. https://doi.org/10.1093/ajcn/86.1.74 CrossRefPubMed

Serra-Majem L, Nissensohn M, Overby NC, Fekete K (2012) Dietary methods and biomarkers of omega 3 fatty acids: a systematic review. Br J Nutr 107(Suppl 2):S64–76. https://doi.org/10.1017/s000711451200147x CrossRefPubMed

Patterson AC, Chalil A, Aristizabal Henao JJ, Streit IT, Stark KD (2015) Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA. Nutr Res 35(12):1040–1051. https://doi.org/10.1016/j.nutres.2015.09.016 CrossRefPubMed

Calder PC (2012) Mechanisms of action of (n-3) fatty acids. J Nutr 142(3):592S–599S. https://doi.org/10.3945/jn.111.155259 CrossRefPubMed

Calder PC (2010) Omega-3 fatty acids and inflammatory processes. Nutrients 2(3):355–374. https://doi.org/10.3390/nu2030355 CrossRefPubMedPubMedCentral

Kong W, Yen JH, Vassiliou E, Adhikary S, Toscano MG, Ganea D (2010) Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids Health Dis 9:12. https://doi.org/10.1186/1476-511X-9-12 CrossRefPubMedPubMedCentral

Guo XF, Yang B, Tang J, Li D (2018) Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials. Clin Nutr 37(1):113–122. https://doi.org/10.1016/j.clnu.2017.01.003 CrossRefPubMed

Oya J, Nakagami T, Sasaki S, Jimba S, Murakami K, Kasahara T, Wasada T, Sekiguchi H, Hasegawa M, Endo Y, Iwamoto Y (2010) Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. Eur J Clin Nutr 64(10):1179–1185. https://doi.org/10.1038/ejcn.2010.139 CrossRefPubMed

10.

Parker HM, Johnson NA, Burdon CA, Cohn JS, O’Connor HT, George J (2012) Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 56(4):944–951. https://doi.org/10.1016/j.jhep.2011.08.018 CrossRefPubMed

11.

Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C, Papa G, Rabuazzo AM, Purrello F (2008) Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 40(3):194–199. https://doi.org/10.1016/j.dld.2007.10.003 CrossRefPubMed

12.

Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, Moyses HE, Calder PC, Byrne CD (2014) Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology 60(4):1211–1221. https://doi.org/10.1002/hep.27289 CrossRefPubMed

13.

Kris-Etherton PM, Innis S, Ammerican Dietetic A, Dietitians of C (2007) Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 107(9):1599–1611. https://doi.org/10.1016/j.jada.2007.07.024 CrossRefPubMed

14.

Cao WT, He J, Chen GD, Wang C, Qiu R, Chen YM (2017) The association between urinary sodium to potassium ratio and bone density in middle-aged Chinese adults. Osteoporos Int 28(3):1077–1086. https://doi.org/10.1007/s00198-016-3835-9 CrossRefPubMed

15.

Zhang CX, Ho SC (2009) Validity and reproducibility of a food frequency Questionnaire among Chinese women in Guangdong province. Asia Pac J Clin Nutr 18(2):240–250PubMed

16.

Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM, Chinese National Consensus Workshop on Nonalcoholic Fatty Liver D (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Digest Dis 9(2):108–112. https://doi.org/10.1111/j.1751-2980.2008.00331.x CrossRef

17.

Petit JM, Guiu B, Duvillard L, Jooste V, Brindisi MC, Athias A, Bouillet B, Habchi M, Cottet V, Gambert P, Hillon P, Cercueil JP, Verges B (2012) Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. Clin Nutr 31(4):520–525. https://doi.org/10.1016/j.clnu.2011.12.007 CrossRefPubMed

18.

Lu W, Li S, Li J, Wang J, Zhang R, Zhou Y, Yin Q, Zheng Y, Wang F, Xia Y, Chen K, Liu T, Lu J, Zhou Y, Guo C (2016) Effects of Omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis. Gastroenterol Res Pract 2016:1459790. https://doi.org/10.1155/2016/1459790 CrossRefPubMedPubMedCentral

19.

He XX, Wu XL, Chen RP, Chen C, Liu XG, Wu BJ, Huang ZM (2016) Effectiveness of Omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. PLoS One 11(10):e0162368. https://doi.org/10.1371/journal.pone.0162368 CrossRefPubMedPubMedCentral

20.

Chen LH, Wang YF, Xu QH, Chen SS (2018) Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 37(2):516–521. https://doi.org/10.1016/j.clnu.2016.12.009 CrossRefPubMed

21.

Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A (2006) Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 23(8):1143–1151. https://doi.org/10.1111/j.1365-2036.2006.02885.x CrossRefPubMed

22.

Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW (2008) Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 14(41):6395–6400CrossRef

23.

Sofi F, Giangrandi I, Cesari F, Corsani I, Abbate R, Gensini GF, Casini A (2010) Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. Int J Food Sci Nutr 61(8):792–802. https://doi.org/10.3109/09637486.2010.487480 CrossRefPubMed

24.

Cazzola R, Russo-Volpe S, Miles EA, Rees D, Banerjee T, Roynette CE, Wells SJ, Goua M, Wahle KW, Calder PC, Cestaro B (2007) Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. Atherosclerosis 193(1):159–167. https://doi.org/10.1016/j.atherosclerosis.2006.06.008 CrossRefPubMed

25.

Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(4):195–203. https://doi.org/10.1038/nrgastro.20 CrossRefPubMed

26.

Scorletti E, Byrne CD (2013) Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr 33:231–248. https://doi.org/10.1146/annurev-nutr-071812-161230 CrossRefPubMed

27.

Wahli W, Michalik L (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 23(7):351–363. https://doi.org/10.1016/j.tem.2012.05.001 CrossRefPubMed

28.

Khan SA, Ali A, Khan SA, Zahran SA, Damanhouri G, Azhar E, Qadri I (2014) Unraveling the complex relationship triad between lipids, obesity, and inflammation. Med Inflamm 2014:502749. https://doi.org/10.1155/2014/502749 CrossRef

29.

Schaeffer L, Gohlke H, Muller M, Heid IM, Palmer LJ, Kompauer I, Demmelmair H, Illig T, Koletzko B, Heinrich J (2006) Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15(11):1745–1756. https://doi.org/10.1093/hmg/ddl117 CrossRefPubMed

30.

Takeuchi Y, Yahagi N, Izumida Y, Nishi M, Kubota M, Teraoka Y, Yamamoto T, Matsuzaka T, Nakagawa Y, Sekiya M, Iizuka Y, Ohashi K, Osuga J, Gotoda T, Ishibashi S, Itaka K, Kataoka K, Nagai R, Yamada N, Kadowaki T, Shimano H (2010) Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1 through proteolytic processing and autoloop regulatory circuit. J Biol Chem 285(15):11681–11691. https://doi.org/10.1074/jbc.M109.096107 CrossRefPubMedPubMedCentral

31.

Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G (2010) Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 16(17):1941–1951. https://doi.org/10.2174/138161210791208875 CrossRefPubMed

32.

Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23(6):1946–1957. https://doi.org/10.1096/fj.08-125674 CrossRefPubMedPubMedCentral

33.

Calder PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851(4):469–484. https://doi.org/10.1016/j.bbalip.2014.08.010 CrossRefPubMed

34.

Calder PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 75(3):645–662. https://doi.org/10.1111/j.1365-2125.2012.04374.x CrossRefPubMedPubMedCentral

35.

Patterson AC, Metherel AH, Hanning RM, Stark KD (2014) The percentage of DHA in erythrocytes can detect non-adherence to advice to increase EPA and DHA intakes. Br J Nutr 111(2):270–278. https://doi.org/10.1017/s0007114513002225 CrossRefPubMed

36.

Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40(6):1387–1395. https://doi.org/10.1002/hep.20466 CrossRefPubMed

37.

Gong W, Liu A, Yao Y, Ma Y, Ding C, Song C, Yuan F, Zhang Y, Feng G, Chen Z, Ding G (2018) Nutrient supplement use among the chinese population: a Cross-Sectional Study of the 2010(-)2012 China Nutrition and Health Surveillance. Nutrients. https://doi.org/10.3390/nu10111733 CrossRefPubMedPubMedCentral

Titel: Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study
verfasst von: Zhan-yong Chen
Meng Liu
Li-peng Jing
Mian-li Xiao
Hong-li Dong
Geng-dong Chen
Yu-ming Chen
Publikationsdatum: 01.04.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 3/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-01953-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study

Abstract

Purpose

Methods

Results

Conclusions

Trial registrations

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Trial registrations

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols

Plasma concentrations and ACE-inhibitory effects of tryptophan-containing peptides from whey protein hydrolysate in healthy volunteers

Age and time trends in sugar intake among children and adolescents: results from the DONALD study

Consumption of fried foods and risk of atrial fibrillation in the Physicians' Health Study

Associations between long-term adherence to healthy diet and recurrent depressive symptoms in Whitehall II Study

Modeled industry-wide food and beverage reformulations reduce the gap between current and nutritionally adequate dietary intakes among French adults

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin